Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review.

Archibald, William J; Kouides, Peter A; Refaai, Majed A; Lachant, Neil A

Archibald, William J; Kouides, Peter A; Refaai, Majed A; Lachant, Neil A.

Afiliação

Archibald WJ; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry.
Kouides PA; Mary Gooley Hemophilia Center, Rochester Regional Health.
Refaai MA; Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Lachant NA; James P Wilmot Cancer Institute, Division of Hematology and Medical Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry.

Blood Coagul Fibrinolysis ; 34(7): 427-431, 2023 Oct 01.

Article em En | MEDLINE | ID: mdl-37695569

Assuntos

Hemofilia A; Doenças de von Willebrand; Humanos; Inibidores de Checkpoint Imunológico; Doenças de von Willebrand/complicações; Hemostasia; Hemofilia A/complicações

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Hemofilia A Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Blood Coagul Fibrinolysis Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google